SC 13D

Company

Merck & Co., Inc.

Filed

March 4, 2021

Accession Number

0001193125-21-068374

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →